Jump to ContentJump to Main Navigation
Comprehensive Handbook of Childhood Cancer and Sickle Cell DiseaseA Biopsychosocial Approach$
Users without a subscription are not able to see the full content.

Ronald T. Brown

Print publication date: 2006

Print ISBN-13: 9780195169850

Published to Oxford Scholarship Online: November 2020

DOI: 10.1093/oso/9780195169850.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (oxford.universitypressscholarship.com). (c) Copyright Oxford University Press, 2021. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in OSO for personal use. date: 16 June 2021

Pain Management of Sickle Cell Disease

Pain Management of Sickle Cell Disease

Chapter:
(p.514) 27 Pain Management of Sickle Cell Disease
Source:
Comprehensive Handbook of Childhood Cancer and Sickle Cell Disease
Author(s):

Nicole F. Swain

Scott W. Powers

Publisher:
Oxford University Press
DOI:10.1093/oso/9780195169850.003.0036

Acute and chronic pain episodes are common experiences for many individuals living with sickle cell disease (SCD). The management of pain related to SCD is primary palliative and includes pharmacological, nonpharmacological, and preventive therapies (Ballas, 2002). This chapter focuses on issues relevant to the assessment and treatment of sickle cell pain in primarily pediatric populations, although some of the adult literature is reviewed, particularly as it relates to children and adolescents. SCD is a hereditary disorder. The disorder primarily affects people of Caribbean and African origin in addition to a small percentage of people of Indian, Mediterranean and Middle Eastern descent (National Association of Health Authorities and Trusts–NAHAT, 1991). SCD is also prevalent in Hispanic and Latino populations. Red blood cells containing sickle hemoglobin become rigid. These cells then become elongated and “sickled” in shape, which makes it very difficult for the sickle cells to move smoothly and flow through microcirculation (Morrison & Vedro, 1989). Symptoms of SCD include chronic anemia, susceptibility to infection, and vaso-occlusive crises or vaso-occlusive episodes (VOEs), resulting in severe pain that can last hours to weeks (Wang, George, & Wilimas, 1988). This vaso-occlusion is caused when sickle cells are unable to flow through arteries, capillaries, arterioles, and other blood vessels and as a result obstruct blood flow. This sickling can occur anywhere in the body, including fingers, arms, ribs, abdomen, and organs such as the brain and eyes (Morrison & Vedro, 1989), but it most commonly occurs in the spleen, bones, and joints (Elander & Midence, 1996). These restrictions in blood flow result in severe pain. In addition, other major clinical problems arise from SCD, including stroke, acute chest syndrome, aseptic necrosis of the hips and shoulders, infections, anemia, leg ulcers, and priapism (Serjeant, 1992). Acute chest syndrome is a significant concern and is the leading cause of mortality in both children and adults with SCD (Platt et al., 1994). Stroke tends to be the most disabling condition and is also a significant cause of death. Stroke in SCD patients accounts for approximately 6% of deaths related to sickle cell disease (Platt et al., 1994).

Keywords:   acupuncture, biofeedback, depressive symptoms, home pain management, massage therapy, opioids, pain management

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .